CATIE HepC Info Update 2.7

Highlights in this issue:

  • High rate of hepatitis C (HCV) virus infection shows young drug injectors need better prevention interventions
  • Hepatitis C transmission via injection drug use: look beyond needles and syringed
  • New telaprevir (Incivek) trials to test drug in different settings
  • Screening baby boomers for hepatitis C may be cost-effective way to reduce complications
  •  Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the HALT-C trial
  • Intensive care of the patient with cirrhosis
  • High uptake of hepatitis C treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic

To read the full update, please click here.